Displaying drugs 14051 - 14075 of 14614 in total
GLPG-0492
Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492).
Investigational
CRA_16847
Experimental
Rabeximod
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Investigational
N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE
Experimental
Spiradoline
Spiradoline has been investigated for the basic science of Bipolar Depression.
Investigational
7-Deazaguanine
Experimental
LY-518674
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
Displaying drugs 14051 - 14075 of 14614 in total